2021 Q1 Form 10-Q Financial Statement
#000112534521000060 Filed on April 29, 2021
Income Statement
| Concept | 2021 Q1 | 2020 Q1 |
|---|---|---|
| Revenue | $16.88M | $13.68M |
| YoY Change | 23.38% | 41.61% |
| Cost Of Revenue | $17.00K | $0.00 |
| YoY Change | ||
| Gross Profit | $16.86M | $13.68M |
| YoY Change | 23.26% | |
| Gross Profit Margin | 99.9% | 100.0% |
| Selling, General & Admin | $15.00M | $10.20M |
| YoY Change | 47.06% | 0.0% |
| % of Gross Profit | 88.95% | 74.55% |
| Research & Development | $53.12M | $48.89M |
| YoY Change | 8.65% | 3.9% |
| % of Gross Profit | 315.0% | 357.36% |
| Depreciation & Amortization | $2.729M | $3.079M |
| YoY Change | -11.37% | 6.06% |
| % of Gross Profit | 16.18% | 22.5% |
| Operating Expenses | $53.12M | $48.89M |
| YoY Change | 8.65% | 3.9% |
| Operating Profit | -$51.29M | -$45.45M |
| YoY Change | 12.87% | -4.56% |
| Interest Expense | ||
| YoY Change | ||
| % of Operating Profit | ||
| Other Income/Expense, Net | $21.00K | $721.0K |
| YoY Change | -97.09% | -72.27% |
| Pretax Income | -$51.30M | -$44.70M |
| YoY Change | 14.77% | -0.67% |
| Income Tax | ||
| % Of Pretax Income | ||
| Net Earnings | -$51.27M | -$44.72M |
| YoY Change | 14.64% | -0.65% |
| Net Earnings / Revenue | -303.73% | -326.88% |
| Basic Earnings Per Share | -$0.90 | |
| Diluted Earnings Per Share | -$0.90 | -$912.2K |
| COMMON SHARES | ||
| Basic Shares Outstanding | 57.20M shares | 48.98M shares |
| Diluted Shares Outstanding | 57.20M shares |
Balance Sheet
| Concept | 2021 Q1 | 2020 Q1 |
|---|---|---|
| SHORT-TERM ASSETS | ||
| Cash & Short-Term Investments | $343.2M | $170.8M |
| YoY Change | 100.94% | -46.69% |
| Cash & Equivalents | $218.5M | $93.06M |
| Short-Term Investments | $124.7M | $77.80M |
| Other Short-Term Assets | $18.20M | $12.60M |
| YoY Change | 44.44% | 48.24% |
| Inventory | $6.172M | |
| Prepaid Expenses | $12.63M | |
| Receivables | $7.148M | $11.81M |
| Other Receivables | $0.00 | $0.00 |
| Total Short-Term Assets | $374.7M | $195.3M |
| YoY Change | 91.88% | -41.71% |
| LONG-TERM ASSETS | ||
| Property, Plant & Equipment | $40.48M | $46.32M |
| YoY Change | -12.61% | -15.51% |
| Goodwill | ||
| YoY Change | ||
| Intangibles | ||
| YoY Change | ||
| Long-Term Investments | ||
| YoY Change | ||
| Other Assets | $20.25M | $23.81M |
| YoY Change | -14.95% | -3.94% |
| Total Long-Term Assets | $60.73M | $70.13M |
| YoY Change | -13.41% | -11.91% |
| TOTAL ASSETS | ||
| Total Short-Term Assets | $374.7M | $195.3M |
| Total Long-Term Assets | $60.73M | $70.13M |
| Total Assets | $435.4M | $265.4M |
| YoY Change | 64.06% | -35.99% |
| SHORT-TERM LIABILITIES | ||
| YoY Change | ||
| Accounts Payable | $10.35M | $1.956M |
| YoY Change | 428.94% | 111.46% |
| Accrued Expenses | $34.97M | $25.06M |
| YoY Change | 39.53% | -13.14% |
| Deferred Revenue | $3.520M | $9.506M |
| YoY Change | -62.97% | -47.44% |
| Short-Term Debt | $0.00 | $0.00 |
| YoY Change | ||
| Long-Term Debt Due | ||
| YoY Change | ||
| Total Short-Term Liabilities | $53.04M | $39.61M |
| YoY Change | 33.91% | -23.49% |
| LONG-TERM LIABILITIES | ||
| Long-Term Debt | $0.00 | $0.00 |
| YoY Change | ||
| Other Long-Term Liabilities | $258.0K | $515.0K |
| YoY Change | -49.9% | -98.78% |
| Total Long-Term Liabilities | $258.0K | $515.0K |
| YoY Change | -49.9% | -98.78% |
| TOTAL LIABILITIES | ||
| Total Short-Term Liabilities | $53.04M | $39.61M |
| Total Long-Term Liabilities | $258.0K | $515.0K |
| Total Liabilities | $84.91M | $74.84M |
| YoY Change | 13.46% | -20.4% |
| SHAREHOLDERS EQUITY | ||
| Retained Earnings | -$823.1M | -$686.8M |
| YoY Change | 19.84% | 28.31% |
| Common Stock | $1.174B | $877.3M |
| YoY Change | 33.77% | 2.5% |
| Preferred Stock | ||
| YoY Change | ||
| Treasury Stock (at cost) | ||
| YoY Change | ||
| Treasury Stock Shares | ||
| Shareholders Equity | $350.5M | $190.6M |
| YoY Change | ||
| Total Liabilities & Shareholders Equity | $435.4M | $265.4M |
| YoY Change | 64.06% | -35.99% |
Cashflow Statement
| Concept | 2021 Q1 | 2020 Q1 |
|---|---|---|
| OPERATING ACTIVITIES | ||
| Net Income | -$51.27M | -$44.72M |
| YoY Change | 14.64% | -0.65% |
| Depreciation, Depletion And Amortization | $2.729M | $3.079M |
| YoY Change | -11.37% | 6.06% |
| Cash From Operating Activities | -$29.04M | -$44.14M |
| YoY Change | -34.22% | 47.14% |
| INVESTING ACTIVITIES | ||
| Capital Expenditures | $626.0K | $1.253M |
| YoY Change | -50.04% | -25.19% |
| Acquisitions | ||
| YoY Change | ||
| Other Investing Activities | -$33.63M | $11.82M |
| YoY Change | -384.52% | -117.18% |
| Cash From Investing Activities | -$34.26M | $10.56M |
| YoY Change | -424.28% | -114.99% |
| FINANCING ACTIVITIES | ||
| Cash Dividend Paid | ||
| YoY Change | ||
| Common Stock Issuance & Retirement, Net | $98.20M | $0.00 |
| YoY Change | -100.0% | |
| Debt Paid & Issued, Net | ||
| YoY Change | ||
| Cash From Financing Activities | $100.7M | $162.0K |
| YoY Change | 62034.57% | -99.86% |
| NET CHANGE | ||
| Cash From Operating Activities | -$29.04M | -$44.14M |
| Cash From Investing Activities | -$34.26M | $10.56M |
| Cash From Financing Activities | $100.7M | $162.0K |
| Net Change In Cash | $37.37M | -$33.42M |
| YoY Change | -211.82% | -280.5% |
| FREE CASH FLOW | ||
| Cash From Operating Activities | -$29.04M | -$44.14M |
| Capital Expenditures | $626.0K | $1.253M |
| Free Cash Flow | -$29.66M | -$45.40M |
| YoY Change | -34.66% | 43.31% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2021Q1 | dei |
Amendment Flag
AmendmentFlag
|
false | |
| CY2021Q1 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2021 | |
| CY2021Q1 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q1 | |
| CY2021Q1 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001125345 | |
| CY2021Q1 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | |
| CY2021Q1 | dei |
Document Type
DocumentType
|
10-Q | |
| CY2021Q1 | dei |
Document Quarterly Report
DocumentQuarterlyReport
|
true | |
| CY2021Q1 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2021-03-31 | |
| CY2021Q1 | dei |
Document Transition Report
DocumentTransitionReport
|
false | |
| CY2021Q1 | dei |
Entity File Number
EntityFileNumber
|
001-36112 | |
| CY2021Q1 | dei |
Entity Registrant Name
EntityRegistrantName
|
MACROGENICS, INC. | |
| CY2021Q1 | dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
DE | |
| CY2021Q1 | dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
06-1591613 | |
| CY2021Q1 | dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
9704 Medical Center Drive | |
| CY2021Q1 | dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
Rockville | |
| CY2021Q1 | dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
MD | |
| CY2021Q1 | dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
20850 | |
| CY2021Q1 | dei |
City Area Code
CityAreaCode
|
301 | |
| CY2021Q1 | dei |
Local Phone Number
LocalPhoneNumber
|
251-5172 | |
| CY2021Q1 | dei |
Security12b Title
Security12bTitle
|
Common Stock, par value $0.01 per share | |
| CY2021Q1 | dei |
Trading Symbol
TradingSymbol
|
MGNX | |
| CY2021Q1 | dei |
Security Exchange Name
SecurityExchangeName
|
NASDAQ | |
| CY2021Q1 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
| CY2021Q1 | dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | |
| CY2021Q1 | dei |
Entity Filer Category
EntityFilerCategory
|
Large Accelerated Filer | |
| CY2021Q1 | dei |
Entity Small Business
EntitySmallBusiness
|
false | |
| CY2021Q1 | dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
false | |
| CY2021Q1 | dei |
Entity Shell Company
EntityShellCompany
|
false | |
| CY2021Q2 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
60036407 | shares |
| CY2021Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
218496000 | USD |
| CY2020Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
181131000 | USD |
| CY2021Q1 | us-gaap |
Investments
Investments
|
124681000 | USD |
| CY2020Q4 | us-gaap |
Investments
Investments
|
91400000 | USD |
| CY2021Q1 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
7148000 | USD |
| CY2020Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
23081000 | USD |
| CY2021Q1 | us-gaap |
Inventory Net
InventoryNet
|
6172000 | USD |
| CY2020Q4 | us-gaap |
Inventory Net
InventoryNet
|
0 | USD |
| CY2021Q1 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
18222000 | USD |
| CY2020Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
16982000 | USD |
| CY2021Q1 | us-gaap |
Assets Current
AssetsCurrent
|
374719000 | USD |
| CY2020Q4 | us-gaap |
Assets Current
AssetsCurrent
|
312594000 | USD |
| CY2021Q1 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
40475000 | USD |
| CY2020Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
42225000 | USD |
| CY2021Q1 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
20251000 | USD |
| CY2020Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
23924000 | USD |
| CY2021Q1 | us-gaap |
Assets
Assets
|
435445000 | USD |
| CY2020Q4 | us-gaap |
Assets
Assets
|
378743000 | USD |
| CY2021Q1 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
10346000 | USD |
| CY2020Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
8031000 | USD |
| CY2021Q1 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
34965000 | USD |
| CY2020Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
34198000 | USD |
| CY2021Q1 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
3520000 | USD |
| CY2020Q4 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
4456000 | USD |
| CY2021Q1 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
4212000 | USD |
| CY2020Q4 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
3988000 | USD |
| CY2021Q1 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
53043000 | USD |
| CY2020Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
50673000 | USD |
| CY2021Q1 | us-gaap |
Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
|
7260000 | USD |
| CY2020Q4 | us-gaap |
Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
|
6926000 | USD |
| CY2021Q1 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
24353000 | USD |
| CY2020Q4 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
25260000 | USD |
| CY2021Q1 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
258000 | USD |
| CY2020Q4 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
0 | USD |
| CY2021Q1 | us-gaap |
Liabilities
Liabilities
|
84914000 | USD |
| CY2020Q4 | us-gaap |
Liabilities
Liabilities
|
82859000 | USD |
| CY2021Q1 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.01 | |
| CY2020Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.01 | |
| CY2021Q1 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
125000000 | shares |
| CY2020Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
125000000 | shares |
| CY2021Q1 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
60011206 | shares |
| CY2020Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
56244771 | shares |
| CY2021Q1 | us-gaap |
Common Stock Value
CommonStockValue
|
600000 | USD |
| CY2020Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
562000 | USD |
| CY2021Q1 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
1173013000 | USD |
| CY2020Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
1067150000 | USD |
| CY2021Q1 | us-gaap |
Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
|
11000 | USD |
| CY2020Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
|
-7000 | USD |
| CY2021Q1 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-823093000 | USD |
| CY2020Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-771821000 | USD |
| CY2021Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
350531000 | USD |
| CY2020Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
295884000 | USD |
| CY2021Q1 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
435445000 | USD |
| CY2020Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
378743000 | USD |
| CY2021Q1 | us-gaap |
Revenues
Revenues
|
16881000 | USD |
| CY2020Q1 | us-gaap |
Revenues
Revenues
|
13682000 | USD |
| CY2021Q1 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
17000 | USD |
| CY2020Q1 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
0 | USD |
| CY2021Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
53121000 | USD |
| CY2020Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
48894000 | USD |
| CY2021Q1 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
15036000 | USD |
| CY2020Q1 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
10233000 | USD |
| CY2021Q1 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
68174000 | USD |
| CY2020Q1 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
59127000 | USD |
| CY2021Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-51293000 | USD |
| CY2020Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-45445000 | USD |
| CY2021Q1 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
21000 | USD |
| CY2020Q1 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
721000 | USD |
| CY2021Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-51272000 | USD |
| CY2020Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-44724000 | USD |
| CY2021Q1 | us-gaap |
Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
|
18000 | USD |
| CY2020Q1 | us-gaap |
Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
|
56000 | USD |
| CY2021Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-51254000 | USD |
| CY2020Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-44668000 | USD |
| CY2021Q1 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.90 | |
| CY2020Q1 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.91 | |
| CY2021Q1 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
57202846 | shares |
| CY2020Q1 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
49012663 | shares |
| CY2020Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
295884000 | USD |
| CY2021Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
5243000 | USD |
| CY2021Q1 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
98200000 | USD |
| CY2021Q1 | us-gaap |
Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
|
2458000 | USD |
| CY2021Q1 | us-gaap |
Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
|
18000 | USD |
| CY2021Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-51272000 | USD |
| CY2021Q1 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
350531000 | USD |
| CY2019Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
230628000 | USD |
| CY2020Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
4451000 | USD |
| CY2020Q1 | us-gaap |
Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
|
162000 | USD |
| CY2020Q1 | us-gaap |
Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
|
56000 | USD |
| CY2020Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-44724000 | USD |
| CY2020Q1 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
190573000 | USD |
| CY2021Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-51272000 | USD |
| CY2020Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-44724000 | USD |
| CY2021Q1 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
2729000 | USD |
| CY2020Q1 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
3079000 | USD |
| CY2021Q1 | us-gaap |
Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
|
-367000 | USD |
| CY2020Q1 | us-gaap |
Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
|
270000 | USD |
| CY2021Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
5286000 | USD |
| CY2020Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
4491000 | USD |
| CY2021Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-15934000 | USD |
| CY2020Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-938000 | USD |
| CY2021Q1 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
6172000 | USD |
| CY2020Q1 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
0 | USD |
| CY2021Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
1239000 | USD |
| CY2020Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
1345000 | USD |
| CY2021Q1 | us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
-3673000 | USD |
| CY2020Q1 | us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
-695000 | USD |
| CY2021Q1 | us-gaap |
Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
|
1829000 | USD |
| CY2020Q1 | us-gaap |
Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
|
-2286000 | USD |
| CY2021Q1 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
855000 | USD |
| CY2020Q1 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
-2118000 | USD |
| CY2021Q1 | mgnx |
Increase Decrease In Lease Liabilities
IncreaseDecreaseInLeaseLiabilities
|
-683000 | USD |
| CY2020Q1 | mgnx |
Increase Decrease In Lease Liabilities
IncreaseDecreaseInLeaseLiabilities
|
-869000 | USD |
| CY2021Q1 | us-gaap |
Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
|
-601000 | USD |
| CY2020Q1 | us-gaap |
Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
|
-2248000 | USD |
| CY2021Q1 | us-gaap |
Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
|
258000 | USD |
| CY2020Q1 | us-gaap |
Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
|
515000 | USD |
| CY2021Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-29036000 | USD |
| CY2020Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-44142000 | USD |
| CY2021Q1 | us-gaap |
Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
|
93881000 | USD |
| CY2020Q1 | us-gaap |
Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
|
61186000 | USD |
| CY2021Q1 | us-gaap |
Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
|
60250000 | USD |
| CY2020Q1 | us-gaap |
Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
|
73003000 | USD |
| CY2021Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
626000 | USD |
| CY2020Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
1253000 | USD |
| CY2021Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-34257000 | USD |
| CY2020Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
10564000 | USD |
| CY2021Q1 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
98200000 | USD |
| CY2020Q1 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
0 | USD |
| CY2021Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
100658000 | USD |
| CY2020Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
162000 | USD |
| CY2021Q1 | mgnx |
Proceedsfrom Stock Options Exercised And Espp Purchases
ProceedsfromStockOptionsExercisedAndESPPPurchases
|
2458000 | USD |
| CY2020Q1 | mgnx |
Proceedsfrom Stock Options Exercised And Espp Purchases
ProceedsfromStockOptionsExercisedAndESPPPurchases
|
162000 | USD |
| CY2021Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
37365000 | USD |
| CY2020Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-33416000 | USD |
| CY2020Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
181131000 | USD |
| CY2019Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
126472000 | USD |
| CY2021Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
218496000 | USD |
| CY2020Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
93056000 | USD |
| CY2021Q1 | us-gaap |
Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
|
486000 | USD |
| CY2020Q1 | us-gaap |
Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
|
0 | USD |
| CY2020Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | |
| CY2021Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P6Y3M | |
| CY2021Q1 | us-gaap |
Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
|
124670000 | USD |
| CY2021Q1 | us-gaap |
Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
|
14000 | USD |
| CY2021Q1 | us-gaap |
Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
|
3000 | USD |
| CY2021Q1 | us-gaap |
Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
|
124681000 | USD |
| CY2020Q4 | us-gaap |
Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
|
91407000 | USD |
| CY2020Q4 | us-gaap |
Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
|
3000 | USD |
| CY2020Q4 | us-gaap |
Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
|
10000 | USD |
| CY2020Q4 | us-gaap |
Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
|
91400000 | USD |
| CY2021Q1 | us-gaap |
Debt Securities Available For Sale Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
|
0 | USD |
| CY2020Q4 | us-gaap |
Debt Securities Available For Sale Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
|
0 | USD |
| CY2021Q1 | us-gaap |
Inventory Raw Materials
InventoryRawMaterials
|
1215000 | USD |
| CY2021Q1 | us-gaap |
Inventory Work In Process
InventoryWorkInProcess
|
4957000 | USD |
| CY2021Q1 | us-gaap |
Inventory Work In Process And Raw Materials
InventoryWorkInProcessAndRawMaterials
|
6172000 | USD |
| CY2021Q1 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
5286000 | USD |
| CY2020Q1 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
4491000 | USD |
| CY2021Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | |
| CY2020Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P6Y3M | |
| CY2020Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
7258353 | shares |
| CY2020Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
21.48 | |
| CY2020 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P6Y9M18D | |
| CY2021Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
|
1555796 | shares |
| CY2021Q1 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
19.52 | |
| CY2021Q1 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
144249 | shares |
| CY2021Q1 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
17.59 | |
| CY2021Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
66463 | shares |
| CY2021Q1 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
|
17.98 | |
| CY2021Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
8603437 | shares |
| CY2021Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
21.21 | |
| CY2021Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P7Y2M12D | |
| CY2021Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
91820000 | USD |
| CY2021Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
4825295 | shares |
| CY2021Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
22.96 | |
| CY2021Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
|
P5Y8M12D | |
| CY2021Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
|
43209000 | USD |
| CY2021Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
|
8167732 | shares |
| CY2021Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
|
21.32 | |
| CY2021Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
|
P7Y1M6D | |
| CY2021Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
|
86309000 | USD |
| CY2021Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
14.23 | |
| CY2020Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
7.12 | |
| CY2021Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
|
1400000 | USD |
| CY2020Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
|
1100000 | USD |
| CY2021Q1 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
2500000 | USD |
| CY2020Q1 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
200000 | USD |
| CY2021Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
|
4100000 | USD |
| CY2020Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
|
3700000 | USD |
| CY2021Q1 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
|
42300000 | USD |
| CY2021Q1 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
|
P2Y10M24D |
